Management of C. difficile Positive Organism, Toxin Negative

Introduction to C. difficile Infection Management

The World Journal of Emergency Surgery recommends that in patients with C. difficile organism detected but toxin negative, treatment should generally be avoided unless there is strong clinical suspicion for severe CDI, in which case empirical therapy with oral vancomycin 125 mg four times daily should be initiated while awaiting further clinical assessment 1
Toxin-negative results may indicate colonization rather than active infection, as up to 7% of asymptomatic hospitalized patients may be colonized with toxigenic C. difficile 2

Nucleic acid amplification tests (NAAT) detect toxin genes but cannot differentiate between active infection and asymptomatic colonization, which is why single-step NAAT algorithms can increase detection of colonization 2
The sensitivity of toxin A/B enzyme immunoassays (EIA) ranges from only 32-98%, meaning false negatives can occur in true CDI cases 2

The World Journal of Emergency Surgery suggests that do not initiate antibiotic therapy if patient has formed stools or fewer than 3 unformed stools in 24 hours, no fever, abdominal pain, or leukocytosis present, no recent antibiotic exposure or hospital residence, and patient is clinically stable without signs of severe disease 2
Initiate empirical therapy with oral vancomycin 125 mg four times daily if strong clinical suspicion exists, defined by three or more unformed stools in 24 hours with unexplained diarrhea, fever (>38°C) with abdominal pain and leukocytosis, recent antibiotic exposure, elevated serum lactate or creatinine suggesting systemic involvement, or imaging findings suggestive of colitis 1, 2, 3

Discontinue the inciting antibiotic immediately if clinically possible, and if continued antibiotics are necessary, switch to lower-risk agents (parenteral aminoglycosides, sulfonamides, macrolides, vancomycin, or tetracycline/tigecycline) 1, 3
Discontinue unnecessary proton pump inhibitors as part of stewardship practice, though evidence for mandatory discontinuation is limited 1, 3
Avoid antimotility agents (loperamide, diphenoxylate) and antiemetics with antimotility effects (prochlorperazine), as these can prolong toxin retention and worsen outcomes 4

If treatment is started based on strong clinical suspicion, use oral vancomycin 125 mg four times daily for 10 days (not metronidazole), or fidaxomicin 200 mg twice daily for 10 days as an alternative, particularly for elderly patients or those at high risk for recurrence 3, 5
Provide aggressive supportive care including IV fluid resuscitation and electrolyte replacement, and monitor clinical response closely; diarrhea should improve within 3-5 days if true CDI 3, 4